Through $1.15B NIH Project, Researchers Look for Markers of Long COVID for Potential Dx Tests
The four-year National Institutes of Health-funded project is coordinating hundreds of researchers with goals of determining the causes and effects of long COVID.
GLX Analytix has reached a milestone in its quest to use an overlooked class of biomarkers to deliver new molecular tests to market.
Beckman Coulter Nabs $694K BARDA Award to Validate Inflammatory Syndrome Biomarker
The firm was awarded the funding to validate its monocyte distribution width hematology biomarker for the detection of multisystem inflammatory syndrome in children.
DIAMONDS Project Using New Classification Approach to Develop Rapid Infectious Disease Tests
Technology partners on the study include BioMérieux and SkylineDx, as well as Imperial College London's biomedical electronics unit.
Multi-Disease Diagnostic Platform Project Receives €22.5M in EU Funding
An international group of researchers aim to develop an approach that may be able to diagnose multiple conditions, including pneumonia, tuberculosis, sepsis, with one blood sample.